Top Markets
#1 COTI COTI +40.13%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.72%
#3 Bitcoin Cash Bitcoin Cash +31.68%
#4 Fabric Protocol Fabric Protocol +31.09%
#5 GALA GALA +28.74%
#6 Tutorial Tutorial +27.35%
#7 Talus Network Talus Network +26.03%
#8 Magma Finance Magma Finance +24.61%
#9 Zora Zora +23.81%
#10 Arowana Arowana +22.89%
Coin of the day
COTI COTI
Settings
Language
ENGLISH
Currency
USD
Theme
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rank in Stocks #24658
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Share Price
$3.05
Market Cap
$58.15M
Change (1 day)
-0.81%
Change (1 year)
-73.32%
Country
US
Trade Elicio Therapeutics, Inc. (ELTX)

Category

Healthcare
Earnings for Elicio Therapeutics, Inc. (ELTX)
Earnings in 2026 TTM: 0
According to Elicio Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Elicio Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH